Models of Artificial Intelligence-Assisted Diagnosis of Lung Cancer Pathology Based on Deep Learning Algorithms
Author(s) -
Su Chen
Publication year - 2022
Publication title -
journal of healthcare engineering
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.509
H-Index - 29
eISSN - 2040-2309
pISSN - 2040-2295
DOI - 10.1155/2022/3972298
Subject(s) - lung cancer , convolutional neural network , radiology , lung , nodule (geology) , artificial neural network , medicine , false positive rate , machine learning , artificial intelligence , computer science , algorithm , pathology , biology , paleontology
In this article, in order to explore the application of a diagnosis system for lung cancer, we use an auxiliary diagnostic system to predict and diagnose the good and evil attributes of chest CT pulmonary nodules. This research improves the new diagnosis method based on the convolutional neural network (CNN) and the recurrent neural network (RNN) and combines the dual effects of the two algorithms to process the classification of benign and malignant nodules. By collecting H-E-stained pathological slices of 652 patients' lung lesions from two hospitals between January 2018 and January 2019, the output results of the improved 3D U-net system and the consistent results of two-person reading were compared. This article analyzes the sensitivity, specificity, positive flammability rate, and negative flammability rate of different lung nodule detection methods. In addition, the artificial intelligence system’s and the radiologist's judgment results of benign and malignant pulmonary nodules are used to draw ROC curves for further analysis. The improved model has an accuracy rate of 92.3% for predicting malignant lung nodules and an accuracy rate of 82.8% for benign lung nodules. The new diagnostic method using the convolutional neural network and the recurrent neural network can be very effective for improving the accuracy of predicting lung cancer diagnosis. It can play a very effective role in the disease prediction of lung cancer patients, thereby improving the treatment effect.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom